2027 Future Talent Program - Global Lung Medical Affairs - Intern
Merck
Summary
The Future Talent Program features internships that last up to 12 weeks and will include one or more projects. These opportunities in our Research Labs Division can provide you with great development and a chance to see if we are the right company for your long-term goals.
Job description
Collaborate with the Global Medical Affairs Lung team on key strategic projects:
- Support strategic and operational international congress planning and execution (e.g. ASCO, WCLC, ESMO). This will include communications and insights related to priority competitor and internal data readouts.
- Conduct scientific insights analyses using novel AI tools to identify and semi-quantify sentiment themes and translate these findings into actionable recommendations. Additionally, develop a methodology framework outlining how AI tools can be used to analyze scientific insights.
- Collaboration with GMSA Analytics Center of Excellence (ACE) team on global lung projects across V&I priorities.
Expected Gains
You will expand your capabilities and skills in strategic planning and execution of medical international congresses at the global level, in utilization of AI tools to analyze insights and in
You will expand your network within the regional and global cross-functional parts of the organization.
Requirements
- Full-time student pursuing a BS/BA, MS or PharmD/PhD.
- Experience in analyzing medical insights and translating them into actionable outcomes.
- Utilization of AI tools (e.g. prompt building).
- Interest and background within science and pharmaceutical/medical field.
- Oncology experience if available.
Company overview
Merck & Co., Inc., known as Merck in the United States and Canada and MSD (Merck Sharp & Dohme) internationally, is a premier American multinational pharmaceutical company headquartered in Rahway, New Jersey. Founded in 1891 as the U.S. subsidiary of the German Merck Group, the company became independent following World War I and has since grown into one of the world's largest biomedical companies, ranking fourth globally by revenue. Merck operates across three core business segments: pharmaceuticals, vaccines, and animal health products. The company is renowned for its groundbreaking research and development, having brought numerous life-saving medicines to market including Keytruda (pembrolizumab), a leading immunotherapy for cancer treatment that generated $29.5 billion in 2024 revenue, and Gardasil, a revolutionary HPV vaccine. With approximately 75,000 employees worldwide, Merck maintains a robust pipeline of innovative therapies focused on oncology, vaccines, hospital acute care, cardiology, neuroscience, virology, immunology, and diabetes. The company invests heavily in R&D, spending $17.9 billion in 2024 alone, demonstrating its commitment to advancing scientific discovery. Merck's legacy spans over 130 years of bringing hope to humanity through important medicines and vaccines, operating with a purpose to use leading-edge science to save and improve lives globally while fostering an inclusive workforce and responsible business practices.